AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,423 | +29.6% | 638,090 | +4.0% | 0.00% | – |
| Q2 2023 | $561,435 | -18.4% | 613,590 | -50.0% | 0.00% | – |
| Q1 2023 | $687,712 | +94.2% | 1,227,180 | +100.0% | 0.00% | – |
| Q4 2022 | $354,041 | +81.6% | 613,590 | -0.6% | 0.00% | – |
| Q3 2022 | $195,000 | -11.0% | 617,118 | -0.7% | 0.00% | – |
| Q2 2022 | $219,000 | +36.0% | 621,244 | +177.3% | 0.00% | – |
| Q1 2022 | $161,000 | – | 224,001 | +605308.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 37 | -86.8% | 0.00% | – |
| Q1 2021 | $1,000 | -66.7% | 280 | -76.7% | 0.00% | – |
| Q3 2020 | $3,000 | -100.0% | 1,200 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $24,058,000 | +209.3% | 1,771,567 | +72.7% | 0.00% | +200.0% |
| Q1 2020 | $7,778,000 | +649.3% | 1,026,067 | +524.7% | 0.00% | – |
| Q4 2019 | $1,038,000 | +147.1% | 164,259 | +53.3% | 0.00% | – |
| Q3 2019 | $420,000 | -40.3% | 107,168 | -26.2% | 0.00% | – |
| Q2 2019 | $703,000 | -59.5% | 145,242 | -31.4% | 0.00% | – |
| Q1 2019 | $1,734,000 | +46.5% | 211,668 | -1.2% | 0.00% | – |
| Q4 2018 | $1,184,000 | -80.1% | 214,168 | -68.3% | 0.00% | -100.0% |
| Q3 2018 | $5,959,000 | -26.7% | 674,878 | -17.1% | 0.00% | 0.0% |
| Q2 2018 | $8,125,000 | +4.7% | 814,155 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,759,000 | -35.9% | 814,155 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,106,000 | -40.6% | 814,155 | -21.5% | 0.00% | -50.0% |
| Q3 2017 | $20,397,000 | +36.9% | 1,036,955 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,901,000 | +73.8% | 1,036,955 | +11.3% | 0.00% | +100.0% |
| Q1 2017 | $8,573,000 | -11.6% | 931,855 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,701,000 | +15.0% | 931,855 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $8,433,000 | -33.2% | 931,855 | -44.8% | 0.00% | -50.0% |
| Q2 2016 | $12,633,000 | -29.5% | 1,688,855 | -15.1% | 0.00% | 0.0% |
| Q1 2016 | $17,923,000 | -29.4% | 1,989,255 | +1.2% | 0.00% | -33.3% |
| Q4 2015 | $25,396,000 | +33.7% | 1,965,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $18,988,000 | -6.1% | 1,965,600 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $20,226,000 | +151.4% | 1,965,600 | +171.4% | 0.00% | +200.0% |
| Q1 2015 | $8,046,000 | -4.6% | 724,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $8,430,000 | -61.9% | 724,200 | -27.5% | 0.00% | -66.7% |
| Q3 2014 | $22,117,000 | -21.9% | 999,400 | -1.9% | 0.00% | -25.0% |
| Q2 2014 | $28,321,000 | – | 1,019,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |